https://www.selleckchem.com/products/3-typ.html
enting with oligorecurrent pelvic node relapses in prostate cancer were in complete remission after 3yr following combined treatment at the cost of limited toxicity. In this report, we looked at the outcomes of combined high-dose salvage pelvic radiotherapy and 6-mo-long hormone therapy in oligorecurrent pelvic nodal relapse in prostatic cancer. We found that 46% of patients presenting with oligorecurrent pelvic node relapses in prostate cancer were in complete remission after 3 yr following combined treatment at the cost of limited toxic
লাইক
মন্তব্য করুন
শেয়ার করুন
